Dare Bioscience, Inc. (DARE) Operating cash flow 2016–2025
Dare Bioscience, Inc. (DARE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.9MFY2025 · since FY2016: -$372,299 → -$9.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.9M | -280.6% |
| FY2024 | $5.5M | +114.1% |
| FY2023 | -$38.9M | -114.8% |
| FY2022 | -$18.1M | +37.1% |
| FY2021 | -$28.8M | -14.0% |
| FY2020 | -$25.2M | -89.5% |
| FY2019 | -$13.3M | -29.7% |
| FY2018 | -$10.3M | -304.2% |
| FY2017 | -$2.5M | -582.3% |
| FY2016 | -$372,299 | — |
Source: SEC XBRL filings · For reference only · Not investment advice